No products in the cart.
Return To ShopNo products in the cart.
Return To ShopAranesp (darbepoetin alfa) is a synthetic analog of human erythropoietin, produced by Amgen, primarily designed for the treatment of anemia associated with chronic kidney disease and certain cancer treatments. This medication stimulates erythropoiesis, or red blood cell production, in the bone marrow. Administered through subcutaneous injection, Aranesp is available in various dosages, including a potent 20 mcg form. The drug works by mimicking the natural hormone erythropoietin, enhancing the body’s ability to generate red blood cells.
The primary effect of Aranesp is to increase hemoglobin levels in the blood, thereby improving oxygen delivery to tissues. This aspect is particularly relevant in both medical and athletic settings, as red blood cells are crucial for optimal physical performance. Athletes and individuals with certain health conditions often seek treatments that enhance their physical endurance and overall energy levels.
In the realm of sports pharmacology, Aranesp has garnered attention for its ability to enhance athletic performance through increased red blood cell production. This can lead to several notable benefits for athletes:
1. Improved Endurance: Increased hemoglobin levels allow for better oxygenation of muscles, which is critical during prolonged physical activities.
2. Enhanced Recovery: With more oxygen available, athletes may experience quicker recovery times after intense workouts or competitions.
3. Greater Training Capacity: Athletes may find they can train harder and longer without succumbing to fatigue, ultimately increasing their overall performance potential.
4. Anemia Mitigation: Athletes who suffer from fatigue-related anemia might find Aranesp particularly beneficial, as it addresses the root cause of their diminished performance levels.
While the therapeutic effects of Aranesp are impressive, athletes should approach its use with caution due to potential legal and ethical implications within competitive sports. The World Anti-Doping Agency (WADA) has categorized it as a prohibited substance, and misuse can lead to severe sanctions.
Purchasing Aranesp 20 mcg requires careful consideration. It is a prescription medication, so individuals must consult a healthcare provider to assess eligibility and proper usage. Authorized pharmacies that have a valid prescription can provide this medication safely. Additionally, some online pharmacies may offer Aranesp for sale, but it’s crucial to ensure they are legitimate and licensed.
When looking for a verified store, consider the following factors:
– Regulatory Approval: Ensure the pharmacy is accredited by national and local health authorities.
– Customer Reviews: Look for feedback from past customers that attest to the pharmacy’s reliability and quality of service.
– Transparency: A trustworthy pharmacy will provide detailed information about the medication, including side effects and proper usage guidelines.
Avoid purchasing from unregulated sources or vendors claiming to provide Aranesp without a prescription, as this can pose significant health risks and legal issues.
Though Aranesp can offer substantial benefits, it is not suitable for everyone. Certain groups should avoid its use or consult with a healthcare provider beforehand:
1. Individuals with uncontrolled hypertension should avoid Aranesp treatment, as it can exacerbate high blood pressure.
2. Patients with a history of hypersensitivity to darbepoetin alfa or any component of the formulation should refrain from using it.
3. Those with certain types of cancer, particularly those not adequately controlled by treatment, may need to avoid Aranesp due to the potential for tumor development.
4. Individuals with pure red cell aplasia following previous erythropoietin treatment should not use this medication.
5. Pregnant or nursing women should seek medical advice before using Aranesp, as its safety in these situations has not been fully established.
Always consult with healthcare professionals to determine if Aranesp is appropriate, as they can provide tailored advice based on individual health conditions and circumstances.
Determining the correct dosage of Aranesp 20 mcg should be done under the guidance of a healthcare provider. Generally, the dosage may vary based on the condition being treated and the patient’s response. It’s essential to adhere to the prescribed regimen to minimize risks.
– The standard starting dose for treating anemia may vary. It is often administered once every 1 to 4 weeks but should be tailored to individual needs.
– Regular monitoring through blood tests is crucial to assess hemoglobin levels and adjust dosage as necessary.
– Patients should be aware of possible side effects and report any unusual symptoms to their healthcare provider promptly to adjust treatment accordingly.
– Following the prescribed injection technique and storage guidelines is vital to maintain the drug’s effectiveness and safety.
In summary, while Aranesp 20 mcg can offer significant advantages in sports and certain medical conditions, proper guidance and adherence to health regulations are paramount for safe use.
| Active substance | Erythropoietin |
|---|---|
| Classification | Glycoprotein Cytokine |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Detection via specific blood tests (e.g., EPO doping test, isoelectric focusing) |
| Also known as | EPO |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Can cause an increase in blood pressure |
| Trade name | Epogen, Procrit, Eprex, others |
| Storage conditions | Refrigerated, typically between 2-8В°C |
| Chemical name | Erythropoietin |
| Formula | Not applicable as it is a glycoprotein |
| Substance class | Hormone, specifically a growth factor |
| Main action | Stimulates erythropoiesis (production of red blood cells) |
| Half-life | Varies, typically 4-13 hours depending on the type (recombinant forms) |
| Dosage (medical) | Typically 50-300 units/kg three times a week, dose adjusted based on hemoglobin levels and patient response |
| Dosage (sports) | Misuse can involve 20-50 IU/kg of body weight, three times per week |
| Effects | Increases red blood cell count, enhances oxygen transport and aerobic capacity |
| Side effects | Hypertension, thrombosis, increased risk of stroke, headache, flu-like symptoms |
| Use in sports | Banned – used to increase endurance and performance |
| Manufacturer | Amgen |
Reviews
There are no reviews yet.